Biosplice Therapeutics   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: San Diego CA United States (2008)

Organization Overview

First Clinical Trial
2014
NCT02095548
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Biosplice Therapeutics, Inc. | Samumed LLC